FTC Asks 1st Circ. To Reverse Momenta Antitrust Win

Law360, Fort Wayne (November 8, 2016, 2:29 PM EST) -- The Federal Trade Commission on Monday told the First Circuit that a lower court had incorrectly granted immunity to Momenta Pharmaceuticals Inc. from an antitrust suit by Amphastar Pharmaceuticals Inc. and asked the appeals court to reverse that decision.

In his July ruling dismissing the action, U.S. District Judge Nathaniel M. Gorton erroneously applied the Noerr-Pennington doctrine, which states that petitioning the government for redress is generally exempt from antitrust liability, the FTC said. Judge Gorton did not identify any such actions by Momenta before the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.